Solan Headlines

Hereditary Angioedema Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring

 Breaking News
  • No posts were found

Hereditary Angioedema Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring

January 17
18:24 2023
Hereditary Angioedema Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring
The Hereditary Angioedema market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hereditary Angioedema pipeline products will significantly revolutionize the Hereditary Angioedema market dynamics.

DelveInsight’s “Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Hereditary Angioedema market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Hereditary Angioedema market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hereditary Angioedema Market Insights

 

Hereditary Angioedema Overview

Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or mucosal edema, most commonly affecting the skin, intestines, upper respiratory tract, and oropharynx

 

Some of the key facts of the Hereditary Angioedema Market Report: 

  • The Hereditary Angioedema market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • According to NIH, the estimated prevalence of HAE is 1 in 50,000, with reported ranges from 1:10,000 to 1:150,000. The type 1 is estimated to occur in 80% to 85% of HAE patients, whereas type 2 occurs in the remaining 15% to 20%
  • In a study by Lumry, W. R., HAE occurs in approximately 1:30,000–80,000 individuals and affects less than 8,000 individuals in the United States (USA), 15,000 in Europe, and 200,000 worldwide.
  • Key Hereditary Angioedema Companies: Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, and others
  • Key Hereditary Angioedema Therapies: IONIS-PKK-LRx, KVD900, CSL312, and others
  • The Hereditary Angioedema epidemiology based on gender analyzed that Hereditary Angioedema is more prominent in females in comparison to males

 

Get a Free sample for the Hereditary Angioedema Market Report 

https://www.delveinsight.com/sample-request/hereditary-angioedema-market

 

Key benefits of the Hereditary Angioedema Market report:

  1. Hereditary Angioedema market report covers a descriptive overview and comprehensive insight of the Hereditary Angioedema Epidemiology and Hereditary Angioedema market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Hereditary Angioedema market report provides insights on the current and emerging therapies.
  3. Hereditary Angioedema market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Hereditary Angioedema market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Hereditary Angioedema market.

 

Hereditary Angioedema Market  

The dynamics of the Hereditary Angioedema market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.  

 

Hereditary Angioedema Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Hereditary Angioedema Epidemiology Segmentation:

The Hereditary Angioedema market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Hereditary Angioedema
  • Prevalent Cases of Hereditary Angioedema by severity
  • Gender-specific Prevalence of Hereditary Angioedema
  • Diagnosed Cases of Episodic and Chronic Hereditary Angioedema

 

Hereditary Angioedema Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hereditary Angioedema market or expected to get launched during the study period. The analysis covers Hereditary Angioedema market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Hereditary Angioedema Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Hereditary Angioedema market share @ Hereditary Angioedema marketforecast 

 

Hereditary Angioedema Therapies and Key Companies

  • IONIS-PKK-LRx: Ionis Pharmaceuticals
  • KVD900: KalVista Pharmaceuticals
  • CSL312: CSL Behring

 

Hereditary Angioedema Market Drivers

  • Hereditary Angioedema is a complex disorder, efforts have been made by researchers and scientific professionals to improve the understanding of the pathogenesis and diagnosis of this condition 
  • Treatment of Hereditary Angioedema has improved significantly in recent years with the availability of several safe and effective therapies

 

Scope of the Hereditary Angioedema Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Hereditary Angioedema Companies: Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, and others
  • Key Hereditary Angioedema Therapies: IONIS-PKK-LRx, KVD900, CSL312, and others
  • Hereditary Angioedema Therapeutic Assessment: Hereditary Angioedema current marketed and Hereditary Angioedema emerging therapies
  • Hereditary Angioedema Market Dynamics: Hereditary Angioedema market drivers and Hereditary Angioedema market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Hereditary Angioedema Unmet Needs, KOL’s views, Analyst’s views, Hereditary Angioedema Market Access and Reimbursement 

 

Hereditary Angioedema Market Barriers

  • Need of novel and effective treatment for Hereditary Angioedema 
  • Need to develop management guidelines for adolescents and adults with Hereditary Angioedema. 
  • Need for reassessment of doses for Hereditary Angioedema

 

Table of Contents 

1. Hereditary Angioedema Market Report Introduction

2. Executive Summary for Hereditary Angioedema

3. SWOT analysis of Hereditary Angioedema

4. Hereditary Angioedema Patient Share (%) Overview at a Glance

5. Hereditary Angioedema Market Overview at a Glance

6. Hereditary Angioedema Disease Background and Overview

7. Hereditary Angioedema Epidemiology and Patient Population

8. Country-Specific Patient Population of Hereditary Angioedema 

9. Hereditary Angioedema Current Treatment and Medical Practices

10. Hereditary Angioedema Unmet Needs

11. Hereditary Angioedema Emerging Therapies

12. Hereditary Angioedema Market Outlook

13. Country-Wise Hereditary Angioedema Market Analysis (2019–2032)

14. Hereditary Angioedema Market Access and Reimbursement of Therapies

15. Hereditary Angioedema Market Drivers

16. Hereditary Angioedema Market Barriers

17.  Hereditary Angioedema Appendix

18. Hereditary Angioedema Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Hereditary Angioedema treatment, visit @ Hereditary Angioedema Medications 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles